Predictors of surgical site infection in dirty urological surgery

International Journal of Urology

Volumn 15, Issue 8, 2008, Pages 699-703

  Stojadinovic, Miroslav M ^a,b   Mićić, Sava R ^c   Milovanović, Dragan R ^b  

^a CLINICAL CENTRE KRAGUJEVAC   (Serbia)

^b Clinical Centre   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Risk factors; Surgical site infection; Urological surgery

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EMERGENCY SURGERY; ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; KIDNEY ABSCESS; KIDNEY INFECTION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PERCUTANEOUS DRAINAGE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SUPPURATION; SURGICAL INFECTION; TREATMENT OUTCOME; UROLOGIC SURGERY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; UROLOGIC SURGICAL PROCEDURES; YOUNG ADULT;

EID: 49549089545     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02083.x     Document Type: Article

References (26)

1. Kaye KS, Schmader KE, Sawyer R. Surgical site infection in the elderly population. Clin. Infect. Dis. 2004 39 : 1835 41.
2. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, The Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site Infection, 1999. Infect. Control Hosp. Epidemiol. 1999 20 : 250 78.
3. Matsumoto T, Kiyota H, Matsukawa M, Yasuda M, Arakawa S, Monden K. Japanese guidelines for prevention of perioperative infections in urological field. Int. J. Urol. 2007 14 : 890 909.
4. Meakins JL, Masterson BJ. Prevention of postoperative infections. In : Souba WW, Fink MP, Jurkovich GJ, Kaiser LR (eds). ACS Surgery: Principles and Practice. WebMD, New York, 2005 : 17 35.
5. Grabe M. Controversies in antibiotic prophylaxis in urology. Int. J. Antimicrob. Agents 2004 23 (Suppl. 1 S17 23.
6. Hamasuna R, Betsunoh H, Sueyoshi T et al. Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations. Int. J. Urol. 2004 11 : 941 7.
7. WHO Collaborating Center for Drug Statistics and Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs) for Plain Substances. WHO Collaborating Center for Drug Statistics and Methodology, Oslo, 2001.
8. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical would infections. Infect. Control Hosp. Epidemiol. 1992 13 : 606 8.
9. Kasatpibal N, Jamulitrat S, Chongsuvivatwong V. Standardized incidence rates of surgical site infection: a multicenter study in Thailand. Am. J. Infect. Control 2005 33 : 587 94.
10. Kaya E, Yetim I, Dervisoglu A, Sundbul M, Bek Y. Risk factors for and effect of a one-year surveillance program on surgical site infection at a university hospital in Turkey. Surg. Infect. (Larchmt.) 2006 7 : 519 26.
11. Narong MN, Thongpiyapoom S, Thaikul N, Jamulitrat S, Kasatpibal N. Surgical site infections in patients undergoing major operations in a university hospital: using standardized infection ratio as a benchmarking tool. Am. J. Infect. Control 2003 31 : 274 9.
12. Matsukawa M, Kunishima Y, Takahashi S, Takeyama K, Tsukamoto T. Staphylococcus aureus bacteriuria and surgical site infections by methicillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 2001 17 : 327 30.
13. Yamamoto S, Kanamaru S, Kunishima Y, Ichiyama S, Ogawa O. Perioperative antimicrobial prophylaxis in urology: a multi-center prospective study. J. Chemother. 2005 17 : 189 97.
14. Takeyama K, Matsukawa M, Kunishima Y et al. Incidence of and risk factors for surgical site infection in patients with radical cystectomy with urinary diversion. J. Infect. Chemother. 2005 11 : 177 81.
15. Fridkin SK, Edwards JR, Courval JM et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann. Intern. Med. 2001 135 : 175 83.
16. Kolar M, Urbanek K, Vagnerova I, Koukalova D. The influence of antibiotic use on the occurrence of vancomycin-resistant enterococci. J. Clin. Pharm. Ther. 2006 31 : 67 72.
17. Patterson JE. Antibiotic utilization: is there an effect on antimicrobial resistance? Chest 2001 119 : 426 30.
18. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J. Antimicrob. Chemother. 2006 57 : 599 608.
19. Greenstein A, Kaver I, Chen J, Matzkin H. Does preoperative nephrostomy increase the incidence of wound infection after nephrostomy? Urology 1999 53 : 50 2.
20. Yamamoto S, Kunishima Y, Kanamaru S et al. A multi-center prospective study for antibiotic prophylaxis to prevent perioperative infections in urologic surgery. Hinyokika Kiyo 2004 50 : 673 83.
21. Tang HJ, Li CM, Yen MY et al. Clinical characteristics of emphysematous pyelonephritis. J. Microbiol. Immunol. Infect. 2001 34 : 125 30.
22. Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch. Intern. Med. 2000 160 : 797 805.
23. Chen MT, Huang CN, Chou YH, Huang CH, Chiang CP, Liu GC. Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience. J. Urol. 1997 157 : 1569 73.
24. Eklund B, Eklund P, Lindfors O et al. Living donor nephrectomy: surgical aspects. Scand. J. Urol. Nephrol. 1981 64 : 157 61.
25. Waples MJ, Belzer FO, Uehling DT. Living donor nephrectomy: a 20-year experience. Urology 1995 45 : 207 10.
26. Schmidbauer CP, Porpaczy P. Wound healing in urology. Urologe A 1983 22 : 62 6.